Ajuste direto para aquisição de A53311- Acalabrutinib [100 mg; cáp/comp] e T1820- Ticagrelor [60 mg; comp]

ID 11175209 · QuemFatura.pt
Price
Base Price
€29,700 .23
Effective Price
€29,700 .00 -0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
1
Winner
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Company
Competition
1 bidder recorded
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Dates
Publication
20 Jan 2025
Celebration
20 Dec 2024
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
QuemFatura.pt
Api · synced 2026-02-27
Risk Flags
Score 40 · MEDIUM RISK
C3 · Missing Mandatory Fields
C3_MISSING_MANDATORY_FIELDS
LOW
Missing fields
["cpv_code"]
Rule
C3 missing mandatory fields: cpv_code
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17